Burke Brooks is an Oncology physician affiliated with Ochsner Medical Center. OpenAlex indexes 30 publications with 2,341 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9001 Summa Ave
Baton Rouge, LA 708093726
Telephone
225-761-5200Registry record last updated 26 Mar 2010.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ARRAY BIOPHARMA INCProgram year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20251 payment
- Regeneron Healthcare Solutions, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
32.1%Aromatase Inhibitor11%Anastrozole91%Letrozole9%Part D≥110 patientsKinase inhibitor7.4%Ibrance24%Imbruvica19%Calquence14%Imatinib Mesylate13%Cabometyx9%Verzenio5%Inlyta4%Lorbrena4%Tagrisso4%Tasigna4%Part D<11 patients+ 6 more classes in this area
Nervous system
28.2%Opioid Agonist14.8%Oxycodone-Acetaminophen37%Oxycodone Hcl29%Morphine Sulfate Er16%Fentanyl11%Tramadol Hcl4%Hydromorphone Hcl3%Part D<11 patientsBenzodiazepine3.6%Alprazolam77%Diazepam14%Lorazepam8%Part D<11 patients+ 7 more classes in this area
Metabolism & gastrointestinal
11.3%Corticosteroid4.7%Prednisone100%Part D≥38 patientsSerotonin-3 Receptor Antagonist3.3%Ondansetron Hcl66%Ondansetron Odt34%Part D≥23 patients+ 6 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer
International Journal of Radiation Oncology*Biology*Physics
2004 - Photodynamic therapy for corneal neovascularisation and lipid degeneration
British Journal of Ophthalmology
2004 - The Results of combined modality therapy for limited stage small cell lung cancer (LD-SCLC) in the elderly
Journal of Clinical Oncology
2004 - The Results of combined modality therapy for limited stage small cell lung cancer (LD-SCLC) in the elderly
Journal of Clinical Oncology
2004
Similar KOLs
Other experts from the same institution or the same specialty.
Lawrence Blonde, MD
Ochsner Medical Center
Hector Ventura, MD
Ochsner Medical Center
George Pankey, MD
Ochsner Medical Center
Tyrone Collins, MD
Ochsner Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”